HIV cripples B cells too
Nature Immunology
2013년10월28일
HIV glycoprotein gp120, found on the surface of the virus, inactivates human antibody-producing B immune cells, according to a report published this week in Nature Immunology. These findings explain why HIV patients have poor antibody responses.
HIV is known to cause a progressive loss of CD4+ “helper” T immune cells, leading to diminished immune system function and susceptibility to other opportunistic infections. Why robust antibody responses are not generated early in infection, when T cell numbers are still relatively normal, has remained a mystery.
Claudia Cicala and colleagues show that HIV gp120 also directly acts on B cells via the host cell’s surface receptor alpha4-beta7. Signaling through alpha4?beta7 on B cells induces expression of an immunosuppressive molecule and an inhibitory receptor. This gp120-induced response profoundly disables B cells and reduces their ability to produce neutralizing antibodies against the virus.
doi: 10.1038/ni.2746
리서치 하이라이트
-
6월30일
Microbiology: Transmission of gastrointestinal viruses in salivaNature
-
6월29일
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
6월24일
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
6월23일
Scientific community: Women credited less than men in scientific paper authorshipNature
-
6월17일
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
6월16일
An exercise-inducible molecule that suppresses appetiteNature